Tag: Health care industry

Healthy Returns: What’s next for Novo Nordisk’s next-generation obesity drug CagriSema after trial miss

Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen

Novo Nordisk sinks 15% after weight loss drug fails to match Eli Lilly’s in trial

Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China

Kennedy defends Trump glyphosate order; MAHA erupts as midterms approach

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals

FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal

FDA chief Marty Makary says ‘everything should be over-the-counter’ unless drug is unsafe or addictive

Danaher is tapping the M&A well yet again. But we might have had enough